These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25180293)

  • 21. Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression.
    Sakurai D; Zhao J; Deng Y; Kelly JA; Brown EE; Harley JB; Bae SC; Alarcόn-Riquelme ME; ; Edberg JC; Kimberly RP; Ramsey-Goldman R; Petri MA; Reveille JD; Vilá LM; Alarcón GS; Kaufman KM; Vyse TJ; Jacob CO; Gaffney PM; Sivils KM; James JA; Kamen DL; Gilkeson GS; Niewold TB; Merrill JT; Scofield RH; Criswell LA; Stevens AM; Boackle SA; Kim JH; Choi J; Pons-Estel BA; ; Freedman BI; Anaya JM; Martin J; Yu CY; Chang DM; Song YW; Langefeld CD; Chen W; Grossman JM; Cantor RM; Hahn BH; Tsao BP
    PLoS Genet; 2013; 9(10):e1003870. PubMed ID: 24130510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.
    Palafox-Sánchez CA; Oregon-Romero E; Salazar-Camarena DC; Valle YM; Machado-Contreras JR; Cruz A; Orozco-López M; Orozco-Barocio G; Vázquez-Del Mercado M; Muñoz-Valle JF
    Clin Exp Med; 2015 Nov; 15(4):439-46. PubMed ID: 25253090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
    Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
    Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.
    Jenks SA; Wei C; Bugrovsky R; Hill A; Wang X; Rossi FM; Cashman K; Woodruff MC; Aspey LD; Lim SS; Bao G; Drenkard C; Sanz I
    Ann Rheum Dis; 2021 Sep; 80(9):1190-1200. PubMed ID: 34083207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients.
    Shin HD; Park BL; Kim LH; Lee HS; Kim TY; Bae SC
    Hum Mol Genet; 2004 Oct; 13(20):2343-50. PubMed ID: 15333586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE).
    Asokan R; Banda NK; Szakonyi G; Chen XS; Holers VM
    Mol Immunol; 2013 Jan; 53(1-2):99-110. PubMed ID: 22885687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE.
    Boackle SA; Culhane KK; Brown JM; Haas M; Bao L; Quigg RJ; Holers VM
    Autoimmunity; 2004 Mar; 37(2):111-23. PubMed ID: 15293881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mannose-binding lectin (MBL) codon 54 (rs1800450) polymorphism predisposes towards medium vessel vasculitis in patients with systemic lupus erythematosus.
    Negi VS; Devaraju P; Misra DP; Jain VK; Usdadiya JB; Antony PT; Gulati R
    Clin Rheumatol; 2017 Apr; 36(4):837-843. PubMed ID: 28097447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients.
    Isaák A; Gergely P; Szekeres Z; Prechl J; Poór G; Erdei A; Gergely J
    Int Immunol; 2008 Feb; 20(2):185-92. PubMed ID: 18182380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of eNOS 27-bp VNTR (4b/a) gene polymorphism with the risk of Systemic Lupus Erythematosus in south Indian subjects.
    Katkam SK; Indumathi B; Tasneem FSD; Rajasekhar L; Kutala VK
    Gene; 2018 Jun; 658():105-112. PubMed ID: 29524578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis.
    Vazgiourakis VM; Zervou MI; Choulaki C; Bertsias G; Melissourgaki M; Yilmaz N; Sidiropoulos P; Plant D; Trouw LA; Toes RE; Kardassis D; Yavuz S; Boumpas DT; Goulielmos GN
    Ann Rheum Dis; 2011 Dec; 70(12):2184-90. PubMed ID: 21914625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.
    Sohrabian A; Parodis I; Carlströmer-Berthén N; Frodlund M; Jönsen A; Zickert A; Sjöwall C; Bengtsson AA; Gunnarsson I; Rönnelid J
    Arthritis Res Ther; 2019 Nov; 21(1):259. PubMed ID: 31783909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lupus susceptibility region containing CTLA4 rs17268364 functionally reduces CTLA4 expression by binding EWSR1 and correlates IFN-α signature.
    Qi YY; Zhao XY; Liu XR; Wang YN; Zhai YL; Zhang XX; Wang XY; Zhang LJ; Zhao YF; Cui Y; Ning XH; Zhou XJ
    Arthritis Res Ther; 2021 Nov; 23(1):279. PubMed ID: 34736521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of pre-microRNAs genetic variants with susceptibility in systemic lupus erythematosus.
    Zhang J; Yang B; Ying B; Li D; Shi Y; Song X; Cai B; Huang Z; Wu Y; Wang L
    Mol Biol Rep; 2011 Mar; 38(3):1463-8. PubMed ID: 20845080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.
    Tchepeleva SN; Thurman JM; Ruff K; Perkins SJ; Morel L; Boackle SA
    J Immunol; 2010 Aug; 185(4):2331-9. PubMed ID: 20660348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-C1q antibodies in systemic lupus erythematosus.
    Orbai AM; Truedsson L; Sturfelt G; Nived O; Fang H; Alarcón GS; Gordon C; Merrill J; Fortin PR; Bruce IN; Isenberg DA; Wallace DJ; Ramsey-Goldman R; Bae SC; Hanly JG; Sanchez-Guerrero J; Clarke AE; Aranow CB; Manzi S; Urowitz MB; Gladman DD; Kalunian KC; Costner MI; Werth VP; Zoma A; Bernatsky S; Ruiz-Irastorza G; Khamashta MA; Jacobsen S; Buyon JP; Maddison P; Dooley MA; Van Vollenhoven RF; Ginzler E; Stoll T; Peschken C; Jorizzo JL; Callen JP; Lim SS; Fessler BJ; Inanc M; Kamen DL; Rahman A; Steinsson K; Franks AG; Sigler L; Hameed S; Pham N; Brey R; Weisman MH; McGwin G; Magder LS; Petri M
    Lupus; 2015 Jan; 24(1):42-9. PubMed ID: 25124676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.